SCHEMBL18993596

SCHEMBL18993596

c1cnc2cc(-c3ccc4oc(-c5cnc6sccc6c5)cc4c3)oc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 3/20 0.39
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ CYP19A1 P11511 1/20 0.34
▸ CHRNB2 P17787 1/20 0.34
▸ CHRNA4 P43681 1/20 0.34
▸ ABCG2 Q9UNQ0 1/20 0.34
▸ RET P07949 1/20 0.34
▸ APP P05067 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MAOB P27338 2/20 0.32
▸ ADRA2A P08913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28428414 0.68 CHRM2 (0.55) GRM4CHRM2CHRM4CHRM5CHRM1
SCHEMBL18583291 0.68 RIPK1 (0.42) —
SCHEMBL9430009 0.67 CYP1B1 (0.50) GRM4CHRM2CHRM4CHRM5CHRM1
SCHEMBL4142273 0.66 MAOB (0.56) GRM4CHRM2CHRM4CHRM5CHRM1
SCHEMBL14542315 0.66 CHRM2 (0.46) GRM4CHRM2CHRM4CHRM5CHRM1
SCHEMBL19222408 0.65 RIPK1 (0.39) —
SCHEMBL24447710 0.64 BRD4 (0.47) GRM4CHRM2CHRM4CHRM5CHRM1
SCHEMBL19976225 0.64 ALOX5 (0.54) CYP19A1ALOX5NPC1RAB9AMAOB
SCHEMBL7848655 0.63 CHRM2 (0.51) GRM4CHRM2CHRM4CHRM5CHRM1
SCHEMBL10279116 0.63 QPCT (0.43) GRM4CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682953-B2 Amide compounds, compositions and applications thereof ADVINUS THERAPEUTICS LIMITED (IN) 2017-06-20 — — US disclosed
Send feedback